Brachytherapy
Volume 5, Issue 3 , Pages 189-202 , July 2006

The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non–small-cell lung cancer: A systematic review

  • Yee C. Ung

      Affiliations

    • Toronto-Sunnybrook Regional Cancer Centre, Toronto, ON, Canada
    • Corresponding Author InformationCorresponding author. Cancer Care Ontario Program in Evidence-based Care, McMaster University, Downtown Campus, 1280 Main St W, Hamilton, ON, Canada L8S 4L8. Tel.: +1-905-525-9140, ext. 22172; fax: +1-905-522-7681.
    • ,
  • Edward Yu

      Affiliations

    • London Regional Cancer Centre, London, ON, Canada
    • ,
  • Conrad Falkson

      Affiliations

    • Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, ON, Canada
    • ,
  • Adam E. Haynes

      Affiliations

    • Cancer Care Ontario's Program in Evidence-based Care, McMaster University, Hamilton, ON, Canada
    • ,
  • Denise Stys-Norman

      Affiliations

    • Cancer Care Ontario's Program in Evidence-based Care, McMaster University, Hamilton, ON, Canada
    • ,
  • William K. Evans

      Affiliations

    • Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton, ON, Canada
    • ,
  • Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care

      Affiliations

    • Cancer Care Ontario's Program in Evidence-based Care, McMaster University, Hamilton, ON, Canada
    • See the Program in Evidence-based Care section of Cancer Care Ontario's Web site (http://www.cancercare.on.ca/) for a list of current Disease Site Group members.

Received 27 March 2006 ,Revised 16 May 2006 ,Accepted 30 May 2006.

References 

  1. Gaspar LE. Brachytherapy in lung cancer. J Surg Oncol. 1998;67:60–70
  2. Nag S, Kelly JF, Horton JL, et al. Brachytherapy for carcinoma of the lung. Recommendations from the American Brachytherapy Society. Oncology (Huntingt). 2001;15:371–381
  3. Hall EJ. Radiobiology for the radiologist. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;
  4. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995;13:502–512
  5. Langendijk H, de Jong J, Tjwa M, et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non–small cell lung cancer: A prospective randomized study. Radiother Oncol. 2001;58:257–268
  6. Sur R, Ahmed SN, Donde B, et al. Brachytherapy boost vs teletherapy boost in palliation of symptomatic, locally advanced non–small cell lung cancer: Preliminary analysis of a randomized, prospective study. J Brachyther Int. 2001;17:309–315
  7. Sur R, Donde B, Mohuiddin M, et al. Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone. Int J Radiat Oncol Biol Phys. 2004;60;abstr. 127
  8. Chella A, Ambrogi MC, Ribechini A, et al. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: A prospective randomized study. Lung Cancer. 2000;27:169–175
  9. Stout R, Barber P, Burt P, et al. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non–small cell lung cancer. Radiother Oncol. 2000;56:323–327
  10. Huber RM, Fischer R, Hautmann H, et al. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. Int J Radiat Oncol Biol Phys. 1997;38:533–540
  11. Huber RM, Fischer R, Hautmann H, et al. Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules. Chest. 1995;107:463–470
  12. Freitag L, Ernst A, Thomas M, et al. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumor control in patients with limited bronchogenic carcinoma. Thorax. 2004;59:790–793
  13. Escobar-Sacristan JA, Granda-Orive JI, Gutierrez JT, et al. Endobronchial brachytherapy in the treatment of malignant lung tumors. Eur Respir J. 2004;24:348–352
  14. Gejerman G, Mullokandov EA, Bagiella E, et al. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension. Brachytherapy. 2002;1:204–210
  15. Anacak Y, Mogulkoc N, Ozkok S, et al. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non–small cell lung cancer. Lung Cancer. 2001;34:253–259
  16. Ofiara L, Roman T, Schwartzman K, et al. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma. Chest. 1997;112:946–953
  17. Ornadel D, Duchesne G, Wall P, et al. Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy. Lung Cancer. 1997;16:203–213
  18. Perol M, Caliandro R, Pommier P, et al. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest. 1997;111:1417–1423
  19. Delclos ME, Komaki R, Morice RC, et al. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Radiology. 1996;201:279–282
  20. Hernandez P, Gursahaney A, Roman T, et al. High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation. Thorax. 1996;51:354–358
  21. Tredaniel J, Hennequin C, Zalcman G, et al. Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction. Chest. 1994;105:767–772
  22. Goldman JM, Bulman AS, Rathmell AJ, et al. Physiological effect of endobronchial radiotherapy in patients with major airway occlusion by carcinoma. Thorax. 1993;48:110–114
  23. Speiser BL, Spratling L. Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation. Int J Radiat Oncol Biol Phys. 1993;25:589–597
  24. Speiser BL, Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys. 1993;25:579–587
  25. Bedwinek J, Petty A, Bruton C, et al. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys. 1992;22:23–30
  26. Gauwitz M, Ellerbroek N, Komaki R, et al. High dose endobronchial irradiation in recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys. 1992;23:397–400
  27. Mehta M, Petereit D, Chosy L, et al. Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion. Int J Radiat Oncol Biol Phys. 1992;23:133–139
  28. Sutedja G, Baris G, Schaake-Koning C, et al. High dose rate brachytherapy in patients with local recurrences after radiotherapy of non–small cell lung cancer. Int J Radiat Oncol Biol Phys. 1992;24:551–553
  29. Burt PA, O'Driscoll BR, Notley HM, et al. Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron. Thorax. 1990;45:765–768
  30. Fass DE, Armstrong J, Harrison LB. Fractionated high dose rate endobronchial treatment for recurrent lung cancer. Endocurie Hyperther Oncol. 1990;6:211–215
  31. Muto P, Ravo V, Panelli G, et al. High-dose rate brachytherapy of bronchial cancer: Treatment optimization using three schemes of therapy. Oncologist. 2000;5:209–214
  32. Hennequin C, Tredaniel J, Chevret S, et al. Predictive factors for late toxicity after endobronchial brachytherapy: A multivariate analysis. Int J Radiat Oncol Biol Phys. 1998;42:21–27
  33. Taulelle M, Chauvet B, Vincent P, et al. High dose rate endobronchial brachytherapy: Results and complications in 189 patients. Eur Respir J. 1998;11:162–168
  34. Gollins SW, Ryder WD, Burt PA, et al. Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol. 1996;39:105–116
  35. Gollins SW, Burt PA, Barber PV, et al. High dose rate intraluminal radiotherapy for carcinoma of the bronchus: Outcome of treatment of 406 patients. Radiother Oncol. 1994;33:31–40
  36. Macha HN, Wahlers B, Reichle C, et al. Endobronchial radiation therapy for obstructing malignancies: Ten years' experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients. Lung. 1995;173:271–280
  37. Moghissi K, Bond MG, Sambrook RJ, et al. Treatment of endotracheal or endobronchial obstruction by non–small cell lung cancer: Lack of patients in an MRC randomized trial leaves key questions unanswered. Clin Oncol. 2004;11:179–183

PII: S1538-4721(06)00199-1

doi: 10.1016/j.brachy.2006.05.001

Brachytherapy
Volume 5, Issue 3 , Pages 189-202 , July 2006

Article Tools